Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Markers of Radiation Outcome in Patients With Intermediate-Risk Prostate Cancer Using DNA Microarray Analysis: An RTOG Pilot Study

NCT00899912 is registered in ClinicalTrials.gov with Radiation Therapy Oncology Group as lead sponsor.

NCT NCT00899912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00899912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Markers of Radiation Outcome in Patients With Intermediate-Risk Prostate Cancer Using DNA Microarray Analysis: An RTOG Pilot Study
Lead sponsor
Radiation Therapy Oncology Group
Phase
Observational
Overall status
Completed
Start date
June 30, 2006
Completion date
November 30, 2013
Enrollment
13 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer